Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,335 recruiting studies in this area right now.
By phase
- Not applicable4,398
- Phase 2610
- Phase 1411
- Phase 3321
- Phase 4271
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury137
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease105
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,335 total
- NCT06716242Recruiting
A blood test to predict preeclampsia early in pregnancy
This study aims to see if a new blood test can help predict preeclampsia, a serious condition that can occur during pregnancy. It may help identify risk early so that you and your baby can receive the right care.
Alicante, AlicanteAges 18 years+ - NCT06717295Recruiting
Blood test to find cancer early and track treatment
This study uses a blood test that looks at your platelets and immune cells to find common cancers early, and for certain cancers, to monitor how well treatment is working.
RosarioAges 40–75 - NCT06717581Recruiting
Drug interaction study for older people with HIV
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
BolognaAges 18 years+ - NCT06717698RecruitingPhase 2
Testing a new medicine for kidney damage in chronic kidney disease
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
San Dimas, CaliforniaAges 18 years+ - NCT06717815RecruitingPhase 1/Phase 2
Study of IPG11406 for lupus kidney disease
This trial tests a new drug called IPG11406 for people with active lupus nephritis, a type of kidney inflammation caused by lupus. It aims to see if the drug can help reduce kidney damage and improve symptoms.
Hefei, AnhuiAges 18–70 - NCT06718088Recruiting
Studying risk factors for adenomyosis progression
This study looks at what might make adenomyosis (a condition where tissue similar to the uterine lining grows into the muscle wall of the uterus) get worse over time. By tracking volunteers over a period, researchers hope to find patterns or factors that predict progression, which could lead to better monitoring or management.
BolognaAges 18–55 - NCT06718894Recruiting
New treatment strategy for primary podocytopathies
This trial is testing a new treatment approach for people with certain kidney diseases called podocytopathies (like FSGS and MCD). It may help if you have active disease, even after a kidney transplant, or if you have another type of kidney inflammation.
MilanAges Any age - NCT06719089Recruiting
Testing a new biodegradable stent for kidney stone surgery
This trial is testing a new type of temporary tube (stent) that dissolves on its own after being placed in the ureter following kidney stone surgery. It looks at how safe and well the stent works to keep the ureter open while healing.
Aveiro, Aveiro DistrictAges 18 years+ - NCT06719232Recruiting
Testing a new way to give bladder treatment without a catheter
This study tests a catheter-free method for delivering medication directly into the bladder. It may help patients with bladder pain, recurrent infections, bladder cancer, or cystitis after radiation or chemotherapy.
BudapestAges 18–80 - NCT06720532Recruiting
Kidney function in men with prostate cancer getting a new targeted radiation therapy
This study looks at how a targeted radiation therapy called 177Lu-PSMA affects kidney function in men with a type of advanced prostate cancer. It aims to understand risk factors to help guide safe treatment.
MunichAges 18 years+ - NCT06721143RecruitingPhase 1/Phase 2
Study of AION-301 for chronic kidney disease
This trial tests an experimental drug called AION-301 for people with chronic kidney disease (CKD). The goal is to see if it's safe and may help slow kidney decline. It's given by IV infusion and compared to a placebo (inactive infusion).
Miami, FloridaAges 35–75 - NCT06721260Recruiting
Testing metabolism in bladder cancer patients
This trial checks how the body's energy use (metabolism) changes in bladder cancer patients receiving chemotherapy before bladder removal surgery. The goal is to better understand how treatment affects the body.
Kansas City, KansasAges 18 years+ - NCT06721936Recruiting
Study for menopause symptoms after breast cancer
This trial tests a treatment for menopause-like vaginal symptoms that can happen after breast cancer treatment. It aims to help survivors feel more comfortable.
MadridAges 38 years+ - NCT06721975Recruiting
Laser vs laser for kidney stone removal
This trial compares two different lasers used to break up kidney stones during a procedure called flexible ureteroscopy. It may help determine which laser works better and is safer.
San Diego, CaliforniaAges 18 years+ - NCT06723067Recruiting
Wearable breast pump study for mothers of premature babies
This study tests if wearable, wireless breast pumps help mothers of premature infants express milk more often and effectively. Participants will be randomly assigned to use either a wearable pump or a standard hospital pump.
Austin, TexasAges Any age - NCT06723392RecruitingPhase 3
Treating bladder bacteria in pregnancy to prevent infections
This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.
Dhaka, BangladeshAges 18–49 - NCT06723327Recruiting
How urine culture timing affects kidney stone surgery results
This study checks if taking a urine culture two weeks before kidney stone surgery affects outcomes. It may help ensure your surgery goes smoothly by confirming your urine is free of infection.
TekirdağAges 18 years+ - NCT06723353Recruiting
Combined therapy for belly separation in new mothers
This trial tests if a gentle hands-on treatment (visceral manipulation) plus special tape (kinesio taping) can help close the gap in your belly muscles, reduce pain, stop bladder leaks, and improve your pelvic floor strength and overall well-being after childbirth.
Karachi, SindhAges 35–45 - NCT06723938Recruiting
Understanding genetic causes of differences in sex development
This study looks at the genetic and physical traits of people with 46,XY DSD (differences in sex development). It aims to better understand the causes and improve care.
Bologna, BolognaAges Up to 18 years - NCT06724159Recruiting
Study of funded drugs for genitourinary cancers
This study looks at how well newer funded cancer drugs work for people with cancers of the urinary or reproductive systems, such as bladder, prostate, or kidney cancer. Researchers want to learn about real-world outcomes based on routine care in hospitals across Spain.
Albacete, AlbaceteAges 18 years+ - NCT06725810RecruitingPhase 4
Enarodustat for anemia in chronic kidney disease (not on dialysis)
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06725888Recruiting
Vagitab-T for bacterial vaginosis
This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.
Timișoara, Timiș CountyAges 18–65 - NCT06726226Recruiting
Extremely preterm infant lung health study
This study follows the breathing and lung health of very early preterm babies (born before 29 weeks) for two years. It helps doctors understand and improve long-term respiratory care for these tiny infants.
SeoulAges Up to 1 week - NCT06726291RecruitingPhase 4
Akynzeo for nausea in endometrial cancer chemo
This trial tests if Akynzeo (a nausea medicine) helps prevent vomiting during chemotherapy for endometrial cancer. It is for people starting chemo for the first time.
Brescia, BSAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,335 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,288 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.